These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27699825)

  • 1. Elevated C-Peptides, Abdominal Obesity, and Abnormal Adipokine Profile are Associated With Higher Gleason Scores in Prostate Cancer.
    Di Sebastiano KM; Pinthus JH; Duivenvoorden WC; Patterson L; Dubin JA; Mourtzakis M
    Prostate; 2017 Feb; 77(2):211-221. PubMed ID: 27699825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of adipokines in men with prostate cancer and benign prostate hyperplasia.
    Siemińska L; Borowski A; Marek B; Nowak M; Kajdaniuk D; Warakomski J; Kos-Kudła B
    Endokrynol Pol; 2018; 69(2):120-127. PubMed ID: 29465157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study.
    De Nunzio C; Albisinni S; Freedland SJ; Miano L; Cindolo L; Finazzi Agrò E; Autorino R; De Sio M; Schips L; Tubaro A
    Urol Oncol; 2013 Oct; 31(7):997-1002. PubMed ID: 21925906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.
    Shiota M; Takeuchi A; Sugimoto M; Dejima T; Kashiwagi E; Kiyoshima K; Inokuchi J; Tatsugami K; Yokomizo A
    Anticancer Res; 2015 Nov; 35(11):6137-45. PubMed ID: 26504040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adiponectin and leptin levels are useful markers for prostate cancer screening after adjustments for age, obesity-related factors, and prostate volume.
    Nishimura K; Soda T; Nakazawa S; Yamanaka K; Hirai T; Kishikawa H; Ichikawa Y
    Minerva Urol Nefrol; 2012 Sep; 64(3):199-208. PubMed ID: 22971685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal adipokines associated with various types of obesity in Chinese children and adolescents.
    Zhang M; Zhao X; Li M; Cheng H; Hou D; Wen Y; Katherine C; Mi J
    Biomed Environ Sci; 2011 Feb; 24(1):12-21. PubMed ID: 21440835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of plasma levels of adiponectin and c-peptide with risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Stevens VL; Jacobs EJ; Sun J; Gapstur SM
    Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):890-2. PubMed ID: 24585409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
    Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
    Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Association of Waist Circumference and Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort.
    Stevens VL; Jacobs EJ; Maliniak ML; Patel AV; Gapstur SM
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1812-1814. PubMed ID: 29196529
    [No Abstract]   [Full Text] [Related]  

  • 12. Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
    Neuhouser ML; Till C; Kristal A; Goodman P; Hoque A; Platz EA; Hsing AW; Albanes D; Parnes HL; Pollak M
    Cancer Prev Res (Phila); 2010 Mar; 3(3):279-89. PubMed ID: 20179296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
    Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
    Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism during the acute prostate cancer treatment trajectory: The influence of age and obesity.
    Di Sebastiano KM; Bell KE; Mitchell AS; Quadrilatero J; Dubin JA; Mourtzakis M
    Clin Nutr; 2018 Feb; 37(1):195-203. PubMed ID: 27998647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum YKL-40 level with tumor burden and metastatic stage of prostate cancer.
    Özdemir E; Çiçek T; Kaya MO
    Urol J; 2012; 9(3):568-73. PubMed ID: 22903479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
    Burton A; Martin RM; Holly J; Lane JA; Donovan JL; Hamdy FC; Neal DE; Tilling K
    Cancer Causes Control; 2013 Feb; 24(2):323-34. PubMed ID: 23224325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.
    Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.
    Li H; Stampfer MJ; Mucci L; Rifai N; Qiu W; Kurth T; Ma J
    Clin Chem; 2010 Jan; 56(1):34-43. PubMed ID: 19910504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor marker α-fetoprotein receptor does not discriminate between benign prostatic disease and prostate cancer.
    Smrkolj T; Gubina B; Bizjak J; Kumer K; Fabjan T; Osredkar J
    Adv Clin Exp Med; 2017 Oct; 26(7):1085-1090. PubMed ID: 29211355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.